- cafead   Apr 05, 2022 at 11:52: PM
via Just one day after Vas Narasimhan announced $1 billion in cuts amid a company-wide restructuring, the American-Swiss pharma received FDA clearance to produce its spinal muscular atrophy drug Zolgensma out of its North Carolina manufacturing facility.
article source
article source